GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>The problem with sepsis is that basically the body is in full blown nuclear meltdown. It's a very risky indication where many compounds have failed. There are a lot of unknowns.<

Plasma-derived antithrombin is already approved for DIC/sepsis in Japan and some European countries, but I guess that’s a detail that wasn’t consistent with your message.